Union Bancaire Privee, UBP SA
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1716607
GENEVA 1, V8
Position in AUPH
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$220,610
+$27,950 QoQ
Shares Held
13,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 59 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Union Bancaire Privee, UBP SA holds $2,062,233 across 7 Biotechnology names. AUPH ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
15,200 | $1,064,456 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
571 | $356,041 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
This page
|
13,000 | $220,610 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
20,000 | $196,400 | |
| 5 | ABVX |
Abivax S.A.
|
1,100 | $146,586 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
880 | $78,126 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
1 | $14 |
All Filings in AUPH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,610 | 13,000 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $192,660 | 13,000 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $207,350 | 13,000 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $143,650 | 13,000 | Shares | Defined | 2025-10-07 | |
| 2025-03-31 | $104,520 | 13,000 | Shares | Defined | 2025-04-16 | |
| 2024-12-31 | $116,740 | 13,000 | Shares | Defined | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||